| Serial Number | 90812123 |
| Word Mark | AI IS WHERE THE DATA IS |
| Filing Date | Tuesday, July 6, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 5, 2022 |
| Registration Number | 6693951 |
| Registration Date | Tuesday, April 5, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 18, 2022 |
| Goods and Services | Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software |
| Pseudo Mark | ARTIFICIAL INTELLIGENCE IS WHERE THE DATA IS |
| Goods and Services | Statistical services and modeling with respect to cancer treatment and cancer diagnosis |
| Goods and Services | Medical and pharmaceutical services |
| Goods and Services | Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 14, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 14, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 14, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 14, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Immatics Biotechnologies GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Tübingen 72076 DE |
| Party Name | Immatics Biotechnologies GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Tuebingen 72076 DE |
| Party Name | Immatics Biotechnologies GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Tuebingen 72076 DE |
| Event Date | Event Description |
| Wednesday, November 2, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, November 2, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 2, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 2, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, November 2, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 5, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 18, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 18, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 29, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, December 11, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 10, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 10, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 9, 2021 | ASSIGNED TO LIE |
| Monday, December 6, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, September 21, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, September 21, 2021 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, September 21, 2021 | SUSPENSION LETTER WRITTEN |
| Tuesday, September 21, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, September 14, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, July 9, 2021 | NEW APPLICATION ENTERED IN TRAM |